ArticleCureus2026
Optimization of Sutab Preparation for Colonoscopy in Gastric Ulcer Cases: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sutab, a sodium sulfate oral tablet, was developed as an alternative to traditional colonoscopy preparation (prep) solutions, which usually involve the ingestion of about three liters of a polyethylene glycol (PEG) solution to clear the bowels. This traditional method can be unpleasant, leading to barriers for patients seeking colonoscopies due to the large volume of distasteful fluid and resulting diarrhea. Sutab consists of 24 sodium sulfate tablets; patients are instructed to take 12 tablets the night before the procedure with at least 16 ounces of water, followed by another 12 tablets 5-6 hours prior to the colonoscopy. Patients must also consume an additional 32 ounces of water for hydration during the prep. However, as Sutab is relatively new, ongoing research is needed. A few studies indicated potential side effects, including incidences of erosive gastritis and gastric ulcers in patients who used Sutab, raising concerns about its safety, particularly for populations with existing health issues. Here we present a case of a 53-year-old woman who used this method for colonoscopy prep and experienced complications, and aim to provide suggestions on how to mitigate these side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.